Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Sponsored by

Logo 22.07.22.png
Vector circle tech with light blue and lamp bulb on technology b

The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation

The transformation of IP management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises.

This research white paper from CAS explores this transformation at the nexus of IP and research and development (R&D), where organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation earlier in the product lifecycle.

Missing critical IP information during R&D can lead to misallocated resources, potential patent entanglements downstream, and delays in commercialisation. The white paper provides valuable insights for R&D and IP managers about these critical topics:

  • Top IP management goals over the next 12 months;

  • Role and use of IP information across organisations;

  • Challenges in using IP information; 

  • State of IP information access and investments; and 

  • Resolving IP information gaps 

Click here to access CAS’s white paper – “Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D”

Click here to access CAS’s content hub on Managing IP

more from across site and SHARED ros bottom lb

More from across our site

The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application
More than 80 women have entered the top 250 list this year, which includes trailblazing practitioners from more than 50 jurisdictions
IP STARS, Managing IP’s accreditation title, reveals its latest trademark rankings and discloses which firms dominated their respective markets
Today’s rankings release marks a special moment in Managing IP’s calendar, and lawyers should feel proud of their achievements
A new dispute involving Mondelēz and Aldi, and a copyright ruling related to 'Eleanor’ Ford Mustangs were also among the top talking points this week
Via LA’s Qi wireless charging patent pool now covers more than 50% of all SEPs in the space
Vida Panganiban-Alindogan at SyCip Salazar Hernandez & Gatmaitan discusses IP valuation and why no IP practice area is more important than the other
The IP team at Morais Leitão discusses high-stakes litigation, strategic partnerships with clients, and bolstering cross-border expertise
Eszter Szakács discusses 5.30 am wake-ups, legal mind games, and eating Nutella in the middle of the night
Counsel explain how AI can create brand protection headaches, but also be used to fight fakes
Gift this article